Faculty Scholarship
2016

Dual-Seq Transcriptomics Reveals The Battle For Iron During
Pseudomonas Aeruginosa Acute Murine Pneumonia
F Heath Damron
Amanda G. Oglesby-Sherrouse
Angela Wilks
Mariette Barbier

Follow this and additional works at: https://researchrepository.wvu.edu/faculty_publications
Part of the Medicine and Health Sciences Commons

www.nature.com/scientificreports

OPEN

received: 19 July 2016
accepted: 18 November 2016
Published: 16 December 2016

Dual-seq transcriptomics
reveals the battle for iron during
Pseudomonas aeruginosa acute
murine pneumonia
F. Heath Damron1, Amanda G. Oglesby-Sherrouse2,3, Angela Wilks2,3 & Mariette Barbier1
Determining bacterial gene expression during infection is fundamental to understand pathogenesis.
In this study, we used dual RNA-seq to simultaneously measure P. aeruginosa and the murine host’s
gene expression and response to respiratory infection. Bacterial genes encoding products involved in
metabolism and virulence were differentially expressed during infection and the type III and VI secretion
systems were highly expressed in vivo. Strikingly, heme acquisition, ferric-enterobactin transport,
and pyoverdine biosynthesis genes were found to be significantly up-regulated during infection. In the
mouse, we profiled the acute immune response to P. aeruginosa and identified the pro-inflammatory
cytokines involved in acute response to the bacterium in the lung. Additionally, we also identified
numerous host iron sequestration systems upregulated during infection. Overall, this work sheds light
on how P. aeruginosa triggers a pro-inflammatory response and competes for iron with the host during
infection, as iron is one of the central elements for which both pathogen and host fight during acute
pneumonia.
Pseudomonas aeruginosa is an opportunistic Gram-negative respiratory pathogen of major clinical significance
causing acute and chronic respiratory infections as well as bloodstream, urinary tract, burn wound, and surgical
site infections1. According to the Center for Disease Control (CDC), 51,000 healthcare-associated P. aeruginosa
infections occur in the United States each year2. This bacterium is highly versatile, able to survive in harsh environments, and forms robust biofilms that are difficult to eradicate on medical devices. P. aeruginosa is inherently
highly resistant to antibiotics, and effective antimicrobial treatment of infections caused by this bacterium is often
challenging. Multidrug-resistant Pseudomonas cause 13% of all P. aeruginosa infections and were given a threat
level of “serious” in the CDC Antibiotic Resistance Threat report in 20132. Overall, P. aeruginosa carries one of
the highest case fatality rates of all Gram-negative infections3. The success of this microorganism is associated
with its highly adaptive genome, ability to survive and thrive in diverse environments and the expression of a
wide variety of virulence factors4–6. It is therefore important to develop new therapeutics for the treatment of
P. aeruginosa infections.
To accomplish this objective, it is crucial to better understand the simultaneous pathogen and host transcriptional responses during infection. Several studies have attempted to define the interaction dynamics between
the pathogen and the host by studying gene and protein expression of either one or the other7–11. These studies
have identified P. aeruginosa genes and virulence factors involved in bacterial attachment during colonization,
nutrient acquisition, biofilm formation, or resistance to the immune system to facilitate persistence. Numerous
studies have also identified how the host responds to infection12–14 and shown that pathogen-host interaction
drives the selection and co-evolution of the two organisms15–17. More recently, Westermann et al. performed the
first dual-RNA sequencing during tissue culture infection, demonstrating that dual-RNA sequencing is possible
and a great tool to study pathogen-host interactions18.
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Figure 1. Characterization of P. aeruginosa gene expression in vitro and in vivo. (a) Primary cellular
localization of the products of the genes of P. aeruginosa PAO1 differentially regulated in vivo and in vitro. The
percentage of the total number of genes whose expression was significantly up-regulated in vivo compared to
in vitro are represented on the left; the percentage of genes whose expression was significantly up-regulated
in vitro compared to in vivo are represented on the right. Genes were classified according to their known and
predicted cellular localization. (b) Hypergeometric test enrichment analysis on annotation of P. aeruginosa
PAO1 genes differentially regulated in vitro and in vivo. Data are represented as the percentage of genes (hits) in
each class which expression was significantly up-regulated in vitro (green) or in vivo (blue). The subsets in which
the number of hits was significant are denoted with asterisks (***p < 0.001). STRING analysis representing the
300 most highly upregulated P. aeruginosa PAO1 genes expressed in vitro (c) or in vivo (d). Gene products are
represented with circles and known associations between each gene or gene products are represented with a
connecting line. Nodes of genes participating in similar functions are circled in green (expressed in vitro) or in
blue (expressed in vivo).

However, none of these studies have characterized simultaneously the bacterial and host molecular factors
involved in acute lung infection. It has been hypothesized that sequencing the RNA of both the host and the
pathogen during in vivo infection would be feasible19–21 and was recently accomplished during Toxoplasma gondii
infections22. Advances in DNA and protein sequencing during the past decade have now made dual analysis of
RNA and protein expression possible, even in complex tissues. To characterize the armamentarium used in the
battle between P. aeruginosa and the host during acute lung infection, we developed a methodology using dual
RNA-seq to identify the transcriptional response of the pathogen and the host during infection.

Results

Dual genome-wide gene expression analysis during infection.

In this study, we hypothesized that
in vivo conditions influence gene expression in P. aeruginosa during infection and that the bacterium elicits transcriptional changes in the host. To test this hypothesis, we used a murine model of acute pneumonia to characterize the differences in P. aeruginosa gene expression during respiratory infection compared to in vitro growth. Using
dual RNA-seq, we also gained insights into the effects of the bacterium on the host transcriptome. P. aeruginosa
PAO1 was grown on Pseudomonas isolation agar (PIA) at 37 °C and 2 ×  108 colony forming units (CFU) were
used to infect outbred CD-1 mice by intranasal administration. The P. aeruginosa PAO1 grown on PIA was used
to purify RNA for in vitro growth control. Mice were infected with PAO1, or PBS as control. After 16 h, mice
were euthanized, lungs were removed and total RNA was purified. rRNA was depleted, and three libraries were
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Figure 2. Differential expression of bacterial secretion systems in vitro and in vivo. P. aeruginosa secretion
systems expressed in vitro and in vivo were identified using the Kyoto Encyclopedia of Genes and Genomes
(KEGG)24. Proteins encoded by genes up-regulated in vitro are indicated in green while proteins encoded by
genes up-regulated in vivo are shown in blue.

prepared and sequenced using the Illumina MiSeq platform. Read data were mapped to P. aeruginosa and Mus
musculus genomes independently with CLC Genomics.
A total of 87 million 2 × 75 bp reads were obtained. In samples from in vitro culture of PAO1 on PIA, 83%
of the reads mapped to the pathogen, with a total coverage of 99.1% of the open reading frames of P. aeruginosa
PAO1. In infected mice, 11% of the reads mapped to P. aeruginosa, covering 98.2% of the transcriptome, and 64%
of the reads mapped to the mouse transcriptome. A total of 78% of the reads mapped to the non-infected mouse
control. These data indicate that the methodology used in this study provides quality RNA in sufficient quantity
to study the transcriptomes of both the pathogen and the host in the same sample.

P. aeruginosa gene expression changes during infection. Global changes in P. aeruginosa gene expression.

EDGE statistical analysis was used to measure differences in gene expression. A total of 1,887 P. aeruginosa genes
were found to be up-regulated and 1,325 down-regulated in vivo compared to in vitro growth on PIA with a p
value < 0.001 (Table S1). To define the systems differentially regulated in each experimental condition, data were
analyzed using a wide range of metagenomics analysis tools including GO term analysis of the biological processes, hypergeometric tests on annotations, PseudoCAP, KEGG pathways and STRING analysis23–26.
Cellular localization analysis of the gene products expressed by P. aeruginosa indicates that the proportion
of differentially regulated genes whose products are localized in the cytoplasm, cytoplasmic membrane, periplasm, outer-membrane, and extracellular compartment did not significantly change in vitro and during infection
(Fig. 1a). However, genes whose products are associated with outer-membrane vesicles (OMV) were significantly
up-regulated during infection (29 genes associated with OMV formation or OMV-localized products in vitro
against 163 genes in vivo, Table S2). OMVs are produced under stress conditions27 and various authors suggested
that OMVs are involved in resistance to the host immune system by absorbing antimicrobial compounds and
complement28, providing a decoy membrane in the environment29 and delivering virulence factors to host cells
during infection30. Our data seem to indicate that OMV-associated proteins are also important during acute
respiratory infection.
Changes in gene expression associated with bacterial metabolism. STRING and metabolic analyses indicate that
DNA replication, arginine deiminase pathway, gluconeogenesis, cobalamin and choline metabolism, putrescine
transport, and polysaccharide biosynthesis processes were significantly up-regulated during infection (Fig. 1b,d).
These results suggest, as other have previously hypothesized11, that various amino-acids such as arginine, lysine and
proline are available in vivo, and that P. aeruginosa also synthesizes many essential amino-acids during infection.
Genes involved in phenylalanine and cellular amide catabolism, as well as cysteine and unsaturated fatty acid biosynthesis were significantly up-regulated in vitro. Expression of genes from the region PA21XX31, whose products
are involved in carbohydrate metabolism, and alginate production, and of other genes involved in stress response
such as hypochlorite, oxidative stress, and arsenic-containing substances, were significantly increased in vitro,
potentially as a result of the stringent growth conditions encountered in PIA (Fig. 1b,c). Pyocyanin expression
was also found to be up-regulated in vitro, likely as a result of the high magnesium chloride and potassium sulfate
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Figure 3. Comparison between host proteomes and transcriptomes in response to P. aeruginosa infection.
Ingenuity Pathway Analysis (IPA) of canonical pathways significantly up-regulated during P. aeruginosa
infection detected by transcriptome analysis. Murine genes significantly up- or down-regulated during infection
were analyzed using IPA and classified according to their known and predicted function.

concentrations in PIA32. Overall these data suggest that P. aeruginosa adapts to changes in nutrient availability
during infection, primarily as a result of its wide array of metabolic genes.
Non-coding RNA expression during infection. P. aeruginosa encodes within its genome numerous non-coding
RNAs (ncRNA) involved in gene translation such as ribosomal RNAs and transfer RNAs. Other ncRNAs are
involved in post-transcriptional regulation such as crcZ, nalA, phrS, prrF1, prrF2, rsmY, and rsmZ33–35. The expression of crcZ, prrF1, rsmY and rsmZ was detected both in vitro and during infection (RPKM values between 9 and
97,710) (Table S1). The largest number of transcripts detected for a ncRNA in both datasets belonged to crcZ. This
ncRNA is involved in carbon catabolite repression33,36 and was significantly down-regulated during infection (15
fold). The expression of the gene encoding for the RNA chaperone Hfq (−1.4 fold) was also found to be significantly down-regulated during infection (Table S1). Altogether, these data suggest that decreased expression of hfq
and crcZ might play a role in carbon utilization changes observed during infection. rsmZ was the smallest ncRNA
detected (116 bp), suggesting that the method used in this study for RNA extraction and sequencing allows for
detection of small ncRNA expression during infection. However, since the RNA extraction method used in this
study is optimal for fragments over the size of 200 bp, specialized purification procedures designed for RNA fragments of smaller sizes would likely enhance the characterization of small ncRNAs in this type of samples.

Expression of virulence factors during infection.

P. aeruginosa encodes a wide variety of virulence
factors for host colonization and to establish infections. As expected, we observed changes in P. aeruginosa virulence gene expression during acute murine pneumonia. The expression of genes encoding P. aeruginosa type
III (T3SS) and type VI (T6SS) secretion systems which translocate effectors across the bacterial cell envelope
and the eukaryotic cell membrane was significantly increased in vivo (Fig. 2, Table S1). The expression of genes
encoding the T3SS secreted effectors ExoS, ExoT, and ExoY was also up-regulated during infection. These two
systems are involved in eukaryotic cell targeting and P. aeruginosa virulence in vivo37,38. It is important to note
that T3SS and T6SS are usually known to be inversely controlled. Genes encoding the type I and type II secretion
systems were more predominantly expressed in vitro (Fig. 2). Other genes encoding virulence factors such as the
potent exotoxin A (toxA, 5.3 fold) or flagellar biosynthesis (1.62 to 3.55 fold) were up-regulated during infection.
Unlike what was observed in burn wound infections11, the expression of the majority of the genes involved in
LPS biosynthesis (PA3146-PA3159; 1.55 to 3.51 fold) were also up-regulated during infection. However, multiple genes associated with virulence, which would have been predicted to be expressed during infection, were
found to be down-regulated in vivo. For instance, the genes encoding the LasR and RhlR systems involved in
quorum sensing (QS) and regulation of numerous virulence factors were significantly down-regulated in vivo
compared to in vitro conditions. Not surprisingly, 82 QS-regulated genes identified by Wagner et al.39 were also
down-regulated, representing 46% of the QS regulon. This set includes genes involved in the biosynthesis of
virulence factors such as alkaline protease (−1.67 to −4.70 fold), elastase (lasB, −154. fold) and protease IV (piv,
−2.04 fold) (Table S1). This result might be due to differences in cell density between in vitro plate and in vivo
growth conditions. Other non-QS regulated virulence factors were also down-regulated such as phospholipase C
(plcB, −14.98 fold), alginate biosynthesis enzymes (−2.47 to −7.8 fold), and phenazines (−7.81 to −107.97 fold)
Scientific Reports | 6:39172 | DOI: 10.1038/srep39172
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Figure 4. Role of HasR on bacterial burden in mice during acute infection. Mice were infected intranasally
with 108 CFU of PAO1ΔhasR and the parental PAO1 strain. Bacterial burden were determined in the nares
and lung 16 hours post infection. Lung were resuspended in 1 ml PBS and nasal washes were performed with
1 ml of PBS. Data are represented as number of CFU detected in the total volume of sample. Experiments were
performed with 6 mice per group and four technical replicates. Data were analyzed using a two-tailed student
t-test and the software package Graphpad Prism. Statistically significant differences are denoted with asterisks
(*p <  0.05; ***p <  0.0001).

(Table S1). These genes have been shown to be important for P. aeruginosa virulence in various models including
keratitis40, burn wound infections41, or chronic respiratory infections42,43. Decreased expression of these virulence
factors, together with the changes in T3SS and T6SS expression, could be associated with the down regulation
during infection of the two-component system GacA/GacS (−2 .0 and −1.5 fold respectively) which controls both
acute and chronic virulence determinants such as biofilm formation, T6SS, or exopolysaccharide production44–46.
The gene encoding RetS, which controls the planktonic lifestyle and coordinates the production of toxins and the
T3SS through the small RNAs rsmZ and rsmY47, was significantly upregulated in vivo. Interestingly, the expression of the gene encoding for the lost adherence sensor LadS was not significantly changed during infection.
Additionally, increases in expression of both T3SS and T6SS during infection could also be associated with population heterogeneity and changes in expression of other regulatory element, such as the up-regulation of the
contact-dependent PpkA (3.13 fold) regulation of T6SS44. The results obtained here suggest that some virulence
factors might not be required for acute pulmonary infections, but might be expressed in later stages, for instance,
in association with biofilms in chronic lung infections44,48.

M. musculus host response during infection. During infection, various host factors come
into play to control and eliminate bacterial pathogens. To better understand the expression of these
factors, EDGE statistical analysis was used to measure differences in gene expression in the lung of
non-infected mice and mice infected with P. aeruginosa. The expression of 551 M. musculus genes
increased and the expression of 151 decreased during infection compared to non-infected animals with a
p value < 0.001. Meta-analysis of the data using hyper-geometric tests indicated that 80% of the genes with
increased expression during infection were associated with pro-inflammatory response, chemotaxis, response
to antigens, stress response, and regulation of cell proliferation. Granulocyte colony-stimulating factor
(G-CSF or CSF3) was the most up-regulated eukaryotic gene during infection with a fold change of 706.23
(p =  8.93 ×  10−104). The expression of genes encoding other cytokines were also significantly increased during
infection, including the pro-inflammatory cytokines IL1, IL8, tumor necrosis factor alfa (TNF-α), interferon
gamma (IFN-γ), and CSF2. CXC-motif chemokines (CXCL1, 2, 5, 9, 10 and 16), CC-motif chemokines (CCL2,
3, 4, 5, 7, 9, 11, 17 and 20), and the chemokine receptors IL1R2, IL4R, IL17R, and IL18RAP. The genes encoding
FAS and TNFR2 were also highly expressed during infection, together with genes whose products are involved
in TNF and NFκB signaling (Fig. 3, Table S3). These changes in chemokine expression were likely due to LPS
and flagellin recognition by the Toll-like receptors (TLR) 2 and 449–53. The genes encoding CD14 (42.55 fold) and
MyD88 (5.54 fold), two proteins involved in signaling trough TLR4, had increased expression levels during infection (Fig. 3, Table S3). The expression of the gene encoding TLR2, associated with susceptibility to P. aeruginosa
infections54, was also found to be up-regulated during infection (10.85 fold). These data are in agreement with
findings from numerous studies highlighting the importance of Toll-like receptors (TLR) in the recognition of
P. aeruginosa during infection55–59. Interestingly, while T3SS effectors, such as ExoS have been shown to inhibit
the expression of IL-1β60, the expression of this chemokine was up-regulated in vivo (13.69 fold). Altogether,
chemokine expression is responsible for leukocyte differentiation, activation and recruitment, the production
and release of pro-inflammatory cytokines, and play a major role in host defense against P. aeruginosa9. These
chemokines can also be sensed by P. aeruginosa proteins such as OprF and affect gene expression in response to
proinflammatory signals61.
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Figure 5. Iron scavenging and regulation in vivo. (a) Macrophages acquire iron via transferrin receptor
(TRF)-mediated endocytosis of transferrin or via recycling of senescent erythrocytes. Macrophages degrade
heme using heme oxygenase to generate iron, biliverdin and carbon monoxide. Iron is then transferred to the
cytoplasm by DMT1 and either stored using ferritin or released using ferroportin (FPN). (b) During infection,
bacterial recognition by pattern recognition receptors triggers activation of Toll-like receptors (TLR) and
secretion of pro-inflammatory cytokines. As a result, cell release hepcidin to control iron release by FPN.
Proinflammatory cyctokines are also involved in the regulation of Nramp1, which together with FPN deprives
internalized bacteria of iron. TNF-α, IL-1 and IL-6 also stimulate the storage of iron using ferritin. (c) During
infection, bacteria can lyse erythrocytes using various hemolysins and toxins to release heme and hemoglobin.
The host re-captures these iron-rich proteins using haptoglobin and hemopexin, while P. aeruginosa secretes
hemophores such as HasA for heme scavenging. (d) The host uses lactoferrin and transferrin to limit iron
availability during infection. P. aeruginosa secretes siderophores with a high iron affinity such as pyoverdine
to circumvent iron sequestration. In response, the host releases siderocalin/lipocalin-2 to neutralize bacterial
siderophores. Elements that were found to be up-regulated during P. aeruginosa infection in the lung are
indicated in bold black letters. Elements that were unchanged are shown in grey.

Battle for iron during infection.

P. aeruginosa iron acquisition during infection. Iron is a vital nutrient
involved in a wide range of biological processes and enzymatic functions. In low iron conditions, P. aeruginosa
uses siderophores such as pyoverdine and pyochelin to chelate free extracellular Fe3+ 62–64. Pyoverdine binds Fe3+
to form ferripyoverdine. The fpvA gene encodes the ferripyoverdine TonB-dependent receptor (TBDR) FpvA.
This receptor is bound to the anti-σfactor FpvR that sequesters the σfactors PvdS and FpvI to the bacterial
membrane. Binding of ferripyoverdine to FpvA triggers the proteolysis of FpvR, releasing PvdS and FpvI. These
σfactors then associate with the RNA polymerase and drive the expression of fpvA and the genes responsible for
pyoverdine biosynthesis65,66. In our RNA-seq analysis, the expression of fpvA was increased in vivo (7.41 fold),
while the expression levels of fpvI, fpvR and pvdS were unchanged (Table S1). This result suggests that in vivo, ferripyoverdine binding to FpvA triggers the release of PvdS and FpvI. As a result, pyoverdine expression levels are
significantly up-regulated during infection (pvdADEFGHJLNOPQRT), supporting established in vitro models65,66.
The gene expression of the alternative ferripyoverdine receptor, encoding FpvB, was also up-regulated in vivo
(4.86 fold) (Table S1). Previous studies have shown the importance of the expression of this system in vivo;
pyoverdine and FpvA mutants show decreased virulence compared to the parental strain in establishing murine
pulmonary infections67,68. The expression of genes used to produce pyochelin, which has a lower affinity for iron
than pyoverdine63, were also up-regulated in vivo. The pchABCD operon was expressed 40 to 50 fold more in vivo
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than in vitro and the genes pchREFG were expressed over 20 fold more in vivo. pchA was found amongst the genes
most highly expressed in vivo (Table S1).
P. aeruginosa is also able to obtain heme from hemoproteins using the Has and Phu sytems69,70. In the Has
system, the heme is extracted by the hemophore HasAp, which delivers the iron through the TBDR HasR. In the
Phu system, the TBDR PhuR directly extracts the heme. In both pathways, heme is then transported to the cytoplasm by an ABC transporter, bound to a heme chaperone, PhuS, before being delivered to the heme oxygenase
HemO71. In this RNA-seq study, hasAp was the most highly expressed gene in vivo, with differences in expression
of 317.43 fold compared to in vitro settings. The genes hasD (228.00 fold), hasE (177.53 fold), hasR (72.16 fold),
phuR (27.42 fold), phuS (15.00 fold), and hemO (6.39 fold) were also highly expressed in vivo (Table S1). HemO
expression was shown to be necessary to drive the metabolic flow of heme into the cell, with PhuS participating
in heme sensing and acting as a control valve for heme intake and degradation72. Overall, the Has heme acquisition system was the most highly expressed set of genes in vivo, suggesting the importance of iron acquisition
from heme during infection. To validate these findings and determine the contribution of the Has system to
P. aeruginosa pathogenesis, 6 weeks old female CD1 mice were infected intranasally with 108 CFU of PAO1ΔhasR
or the parental strain PAO1. Sixteen hours post infection, mice were euthanized by pentobarbital injection and
the bacterial load in the respiratory tract was determined. In this model of acute respiratory infection, the bacterial load of PAO1ΔhasR was 18.89 fold lower in the lung, and 6.8 fold lower in the nasal washes than the parental
strain (Fig. 4). These data indicate that a mutant lacking the heme receptor HasR was strongly attenuated during
infection. Overall, both RNA-seq and animal infection data suggests, as other have hypothesized in the past73,
that pyoverdine and the Has/Phu systems are involved in acute respiratory infections and play a major role in P.
aeruginosa pathogenesis (Fig. 5).
Iron sequestration by the host during infection. One of the first lines of defense against bacterial infection is the
sequestration of nutrients such as iron to inhibit bacterial growth. During acute infection, the host decreases iron
release into the circulation via hepcidin, increases intracellular iron storage using ferritin, decreases extracellular non-heme iron levels via ceruloplasmin and lactoferrin, and decreases extracellular-heme iron levels using
hemopexin and haptoglobin. Vertebrates also produce lipocalin-2, or neutrophil gelatinase-associated lipocalin
(NGAL), which is secreted by neutrophils in response to infection, and captures bacterial siderophores. In this
study, we observed that RNA levels of genes encoding for the expression of ferritin, ceruloplasmin, lactoferrin
and haptoglobin are increased 4 to 20 fold during P. aeruginosa acute pneumonia (Table 1). However, no changes
were observed in ferroportin, hepcidin, hemopexin, transferrin, or transferrin receptor expression. Additionally,
the expression of norepinephrine, which increases iron availability, was decreased. These results seem to indicate
that during P. aeruginosa infection, the host attempts to sequester iron from the pathogen to limit growth and
dissemination (Fig. 5).

Discussion

In this study, we determined the changes in P. aeruginosa and host gene expression in the context of an acute
murine pneumonia. As expected, we observed that P. aeruginosa expressed numerous virulence factors during
infection, including T3SS and T6SS. P. aeruginosa was found to up-regulate outer membrane vesicle formation
and modify its metabolism in response to infection. In the past, we observed that arginine metabolism responded
to changes of temperature corresponding to the transition from the environment to the host7. In this dataset, we
were able to confirm that arginine metabolism gene expression is also increased during infection, suggesting
that P. aeruginosa adapts its metabolism in response to nutrient availability such as arginine. Overall, there is an
important overlap between the data obtained here and gene expression changes observed in acute and chronic
burn wounds infections11 (T3SS, T6SS, iron acquisition, amino-acid metabolism). This overlap suggests, as others
have hypothesized, that while a core set of virulence genes are required to cause infection, P. aeruginosa adaptation to the lung requires the coordinated expression of genes involved in both virulence and metabolism11,74.
Infection with P. aeruginosa triggered a strong innate immune response and a cytokine storm mediated by
TLR and MyD88 signaling. These data are in agreement with various studies showing that P. aeruginosa and
outer-membrane vesicles are strong agonists of TLR pathogen-associated molecular pattern receptors75–77.
Additionally, we observed that the expression of numerous host proteins involved nutritional immunity78 were
increased during infection. In particular, proteins participating in iron sequestration were up-regulated during
infection, including ferritin, ceruloplasmin, lactoferrin, and haptoglobin. Iron is an essential nutrient required
by both mammalian hosts and pathogens, and the race for iron is undoubtedly crucial during infection. In the
mammalian host, iron is not freely available and is bound to heme molecules found in hemoproteins or chelated
by extracellular proteins such as lactoferrin and transferrin79. During infection, P. aeruginosa sequesters free
iron using siderophores and scavenges iron from heme using the Has and Phu heme acquisition systems. One of
the most striking observation in this study was the expression levels of the P. aeruginosa Has heme acquisition
system during infection (over 300 fold up-regulated compared to in vitro conditions for hasAp). Pyoverdine and
pyochelin siderophores, together with the Phu heme acquisition system were also up-regulated, suggesting that
bacteria are starved for iron during infection. Up-regulation of both heme and siderophores systems in vivo is
likely controlled by the master iron regulator Fur, as no significant changes in expression of the ncRNA prrF1,2
and prrH were observed during infection80. Additionally, both HasAp and PhuS could also be involved in heme
sensing and might be up-regulated during infection in response to the presence of heme in the lung72. Numerous
studies have demonstrated the importance of siderophores in bacterial virulence and colonization81, and authors
have shown that pyoverdine production can be detected in the sputum of CF patients82. It has also been shown
that P. aeruginosa interaction with epithelial cells in vitro in presence of iron is sufficient to up-regulate pyoverdine acquisition genes83. Siderophores have a high affinity for iron, can displace iron from host NGAL and
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Fold up-regulated
during infection

p-value

Lipocalin 2

30.85

8.34E-04

Gene name Description
Lcn2
Ltf

Lactotransferrin

14.34

2.16E-05

Fth1

Ferritin heavy chain 1

6.27

2.33E-03

Cp

Ceruloplasmin

4.82

2.83E-05

Hba-a1

Hemoglobin alpha, adult chain 1

2.11

3.12E-03

Hba-a2

Hemoglobin alpha, adult chain 2

2.96

3.03E-04

Hbb-bs

Hemoglobin beta adult s chain

2.07

1.98E-03

Hbb-bt

Hemoglobin beta adult t chain

2.54

1.89E-04

Steap4

Metalloreductase able to reduce Fe3+to Fe2+using NAD+as receptor

20.64

4.59E-05

Slc39a14

Soluble metal carrier protein

17.85

2.69E-05

Fbxl5

F-box and leucin-rich repeat protein 5, iron sensor

5.72

1.65E-05

Picalm

Phosphatidylinositol binding clathri assembly protein, transferrin receptor internalization

3.74

3.45E-05

Scd2

Stearoyl-coenzyme A desaturase 2, iron binding and oxydoreductase activity

−1.9

5.54E-05

Mmp8

Metallopeptidase 8

34.28

2.57E-05

Mmp9

Metallopeptidase 9

13.82

2.28E-05

Table 1. Host iron-associated genes differentially regulated during P. aeruginosa infection. Fold changes
were calculated by comparing infected to non-infected mice. Fold changes greater than 1 indicate that the gene
was up-regulated during infection compared to in vitro growth conditions. Fold changes inferior to −1 indicate
that the gene was down-regulated during infection compared to in vitro growth conditions.
transferrin for iron piracy, and have been shown to also act as toxins84. While others have suggested that other
iron acquisition systems such as Has and Phu play a role in P. aeruginosa pathogenesis73, their use as an alternative
iron acquisition system during infection has been underappreciated. The data presented here strongly suggests
that heme acquisition by the Has/Phu systems play a crucial role for iron acquisition in vivo. Others have shown
that iron and heme utilization by P. aeruginosa depends on disease progression, and suggested that heme acquisition is characteristic of chronic P. aeruginosa infections85,86. Isolates from chronic CF respiratory infections
were shown to become more efficient in heme utilization by up-regulating PrrF and HemO expression86. In our
dataset, heme acquisition also seems to play a major role in acute infection. For this reason, it would be interesting
to further define the timing and synergy of heme and iron acquisition systems in P. aeruginosa during infection.
While siderophores have been used as a therapeutic target87,88, it is crucial to determine the therapeutic potential
of heme acquisition inhibitors in P. aeruginosa. Seminal studies have paved the way to understand the role of gene
expression in P. aeruginosa pathogenesis11,41,74. Current advances in technology now allow us to study bacterial
pathogenesis from a more systematic approach19. We anticipate that the methodology described in this study will
further our understanding of pathogen-host interactions and be applicable in a wide range of systems to facilitate
the development of novel therapeutics.

Experimental procedures. Bacterial strains and growth media. P. aeruginosa type strain PAO1 was originally obtained from Dr. Michael L. Vasil (University of Colorado). PAO1ΔhasR was obtained from Dr. Angela
Wilks70 (University of Maryland). P. aeruginosa was grown in Pseudomonas isolation agar (Becton Dickinson,
Franklin Lakes, NJ) for 16h at 37 °C before infection.
Infection model. P. aeruginosa PAO1 was grown as described above. Bacteria were swabbed off the plate and
resuspended in phosphate buffered saline (PBS) at a concentration of 1010 colony forming units (CFU) per ml. A
fraction of that suspension was centrifuged and resuspended in RNA protect to measure bacterial gene expression
in vitro before infection. Twenty outbred six weeks old female CD1 mice (Charles River, Frederick, MD) were
anesthetized by injection of ketamine and xylazine. Ten microliters of the bacterial suspension were administered to each nostril (108 CFU/mouse). Ten mice were infected with PAO1, and 10 mice were administered PBS
vehicle control. Sixteen hours post-infection, mice were euthanized by exposure to carbon dioxide. Lungs were
extracted from 4 mice per group and 3 immediately placed in bacterial RNA protect (Qiagen, Germantown, MD)
to prevent RNA degradation. The remaining lung was homogenized in PBS and serial dilutions were plated to
determine the load in the lung. Sixteen hours post infection, approximately 109 CFU were detected in the lung of
each mouse (data not shown). To determine the role of hasR on P. aeruginosa pathogenesis, mice were infected as
described above with 108 CFU of PAO1ΔhasR or the parental strain PAO1. After 16 hours of infection, mice were
euthanized as described above, and nasal washes and lungs were obtained. Lungs were placed into 1 ml of PBS and
homogenized. Nasal washes and lung homogenates were then diluted in PBS, and plated on Lysogeny agar (LA)
to determine the number of viable bacteria. Data were analyzed using a two-tailed student t-test and the software
package Prism 7 (GraphPad, La Jolla, CA). These experiments were performed in accordance with the National
Institutes of Health guide for the care and use of laboratory animals. The protocols used were approved by the
University of Virginia and West Virginia University Institutional Animal Care and Use Committees.
RNA purification and RNA-seq Illumina library preparation and sequencing. RNA was isolated from bacteria
grown in vitro on PIA plates using RNeasy Mini Kit (Qiagen) as specified by the instructions of the manufacturer.
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Briefly, cells were pelleted by centrifugation at 8,000 g and RNA protect was pipetted off. Cell were lysed using
200 μl of TE lysozyme for 5 min at room temperature. Cells were then mixed with 700 μl of RLT and 500 μl of 70%
ethanol. RNA was then applied to RNeasy purification columns and cleaned with RW1 and RPE buffers. RNA
was eluted, treated with RNase-free DNase (Qiagen), and cleaned up on another RNeasy Mini column. RNA was
isolated from the lung using the same kit with the following modifications: after removing the RNA protect, each
lung was homogenized mechanically for 1 min in 667 μl of TE with 1 mg/ml of lysozyme. A total of 2.33 ml of
RLT buffer was then added and tissue was homogenized again for 1 min. Samples were centrifuged at 12,000 g for
10 min and supernatant was transferred to a fresh tube. Five ml of 70% ethanol were added and RNA was purified
using 12 RNeasy columns (2 columns per sample). Columns were cleaned with RW1 and RPE buffers, and RNA
was eluted. The RNA extracted from the two columns per sample was pooled, treated with RNase-free DNase
(Qiagen), and cleaned up using an RNeasy Mini column.
The resulting RNA was quantified on a Nanodrop ND-1000 (Nanodrop, Wilmington, DE). Next, the RNA
integrity was assessed using Agilent BioAnalyzer RNA Pico chip (Agilent, Santa Clara, CA). All samples were then
submitted to two rounds of eukaryotic and prokaryotic Ribo-zero rRNA depletion (Illumina, San Diego, CA) and
reassessed for RNA integrity. rRNA depleted mRNA samples were then fragmented and prepared into libraries
using Illumina TruSeq RNA library prep kit v2. Libraries were checked for quality control with KAPA qPCR QC
assay (KAPA Biosystems, Wilmington, MA). The libraries were then sequenced on an Illumina MiSeq by the
University of Virginia Department of Biology Genomics Core using Illumina MiSeq v3 2 × 75 bp reads. Three
MiSeq lanes were used and each lane contained one biological sample of infected P. aeruginosa infected lung, one
non-infected lung, and one P. aeruginosa in vitro sample. A total of three lanes were used to obtain for 81 million
2 × 75 bp reads for the three biological replicates of each group. Sequencing data were deposited to the Sequence
Read Archive (SRA) and are available under the reference number SRP090213, BioProject number PRJNA343201.
RNA-seq bioinformatics analyses. RNA-seq reads were analyzed using the software CLC Genomics workbench
7.5.1 (Qiagen). The P. aeruginosa PAO1 genome and annotations were downloaded from the Pseudomonas
Genome Database and Mus musculus genome was downloaded from NCBI. Reads were mapped against the
gene regions of the two genomes using the following settings for mapping: mismatch cost = 2, insertion cost =  3,
deletion cost = 3, length fraction = 0.8, similarity fraction = 0.8. RPKM values were generated using default
parameters for CLC Genomics. Fold changes in gene expression and statistical analyses were performed using an
Extraction of Differential Gene Expression (EDGE) test with the Bonferroni correction89.
Metabolic and gene set enrichment analyses. Genes with differences in gene expression with a p value <  0.001
were mapped on the Kyoto Encyclopedia of Genes and Genomes using KEGG Mapper v.2.524. Gene set enrichment analysis (GSEA) tests were performed using CLC Genomic workbench 7.5.123. Analyses were performed
using gene ontology (GO) terms for biological processes25, with a total of 10,000 permutations. Primary cellular
localization of the gene products was obtained from the P. aeruginosa PAO1 genome annotation downloaded
from the Pseudomonas Genome Database. The 300 genes most highly up and down regulated in the P. aeruginosa
PAO1 gene expression dataset were analyzed and grouped using the STRING 9.1 database of known and predicted interactions26 (string-db.org).
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